Healthcare Services

Blood Screening Market Growth Expected to Reach $5.93 Billion by 2030 with 11.5% CAGR

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Blood Screening Market Expected To Change Between 2026 And 2030?

The blood screening market has seen swift expansion in recent years. It is forecast to grow from $3.44 billion in 2025 to $3.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. Historically, this growth can be attributed to factors such as increasingly strict regulatory screening mandates, an increase in blood donation volumes, a rising incidence of transfusion-transmitted infections, the establishment of centralized blood banks, and the embrace of ELISA-based testing.

The blood screening market is projected to experience rapid growth in the upcoming years. Its valuation is set to reach $5.93 billion by 2030, progressing at a compound annual growth rate (CAGR) of 11.5%. This expansion during the forecast period is attributed to increased investments in advanced screening technologies, a rising demand for rapid and accurate diagnostics, the broadening adoption of molecular testing, the growing integration of AI-driven data analysis, and an elevated focus on global blood safety standards. Significant trends foreseen in this period include the increasing uptake of nucleic acid testing technologies, an escalating demand for high-throughput screening systems, the expanding utilization of automated blood screening instruments, the proliferation of software-integrated screening platforms, and an enhanced emphasis on transfusion safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Economic Or Industry Drivers Are Impacting The Blood Screening Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the blood screening market. Chronic diseases are long-term conditions or illnesses that are typically manageable but not curable, demanding adjustment to both the therapy used to treat the condition and its requirements. Blood screening diligently matches the compatibility between the donor’s and recipient’s blood types during transfusions. Blood transfusions are frequently essential as part of medical treatments for numerous chronic diseases, including autoimmune diseases, hematological disorders, and all forms of cancers. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths globally, accounting for 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year. Therefore, the growing prevalence of chronic diseases is driving the growth of the blood screening market.

How Is The Blood Screening Market Structured Across Different Segments?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Which Trends Are Impacting The Growth Of The Blood Screening Market?

Leading companies active in the blood screening market are developing technologies such as liquid biopsy to enhance the early detection of cancer, improve the monitoring of treatments, and enable personalized medicine approaches. A liquid biopsy is a minimally invasive test that examines blood or other body fluids to identify cancer cells or genetic material from tumors. For instance, in November 2023, Guardant Health, Inc., a US-based biotechnology company, introduced its Shield blood-based screening tests. The Shield test analyzes cell-free DNA (cfDNA) present in the bloodstream, which can indicate the presence of colorectal tumors or precancerous growths. It specifically looks for alterations in DNA fragments that are released into the blood from cancer cells.

Which Major Players Dominate The Blood Screening Market?

Major companies operating in the blood screening market are Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Cepheid Inc., Haemonetics Corporation, Verax Biomedical Inc.

Read the full blood screening market report here:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

What Are The Top-Performing Regions Within The Blood Screening Market?

North America was the largest region in the blood screening market in 2025. The regions covered in the blood screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Blood Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Browse Through More Reports Similar to the Global Blood Screening Market 2026, By The Business Research Company

Drug Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Blood Culture Tests Global Market Report

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

Bleeding Disorder Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795